Keywords: NeuroVive, Sihuan Pharma, CicloMulsion, NeuroSTAT, China, Reperfusion injury, Traumatic brain injury
NeuroVive and Sihuan Pharma to develop and commercialize CicloMulsion and NeuroSTAT in China
Article | 21 November 2012
Swedish mitochondrial medicine firm NeuroVive has announced a collaboration with China’s Sihuan Pharmaceutical Holdings (HKEx: 0460) for the development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
